Mattel Has Been Downgraded by analysts April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Jared Haas Mattel, Inc. (MAT) price target has been reduced from $40 to $33 a share.
